Similar articles for PMID: 20853035

Year	Number of Results
1993	1
2004	2
2007	1
2008	5
2009	7
2010	8
2011	9
2012	8
2013	5
2014	8
2015	5
2022	1
2024	0

1

Impact of breast density on the presenting features of malignancy.

Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M. Arora N, et al. Ann Surg Oncol. 2010 Oct;17 Suppl 3:211-8. doi: 10.1245/s10434-010-1237-3. Epub 2010 Sep 19. Ann Surg Oncol. 2010. PMID: 20853035

2

Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.

Bae MS, Han W, Koo HR, Cho N, Chang JM, Yi A, Park IA, Noh DY, Choi WS, Moon WK. Bae MS, et al. Cancer Sci. 2011 Oct;102(10):1862-7. doi: 10.1111/j.1349-7006.2011.02034.x. Epub 2011 Aug 10. Cancer Sci. 2011. PMID: 21752153 Free article.

3

Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.

Domingo L, Salas D, Zubizarreta R, Baré M, Sarriugarte G, Barata T, Ibáñez J, Blanch J, Puig-Vives M, Fernández A, Castells X, Sala M; INCA Study Group. Domingo L, et al. Breast Cancer Res. 2014 Jan 10;16(1):R3. doi: 10.1186/bcr3595. Breast Cancer Res. 2014. PMID: 24410848 Free PMC article.

4

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH. Wang SL, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029696 Chinese.

5

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A. Basu S, et al. Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226. Cancer. 2008. PMID: 18098228 Free article. Clinical Trial.

6

[Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].

Zhang HM, Zhang BN, Xuan LX, Zhao P. Zhang HM, et al. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):447-51. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950556 Chinese.

7

Presenting features of breast cancer differ by molecular subtype.

Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M. Wiechmann L, et al. Ann Surg Oncol. 2009 Oct;16(10):2705-10. doi: 10.1245/s10434-009-0606-2. Epub 2009 Jul 11. Ann Surg Oncol. 2009. PMID: 19593632

8

Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.

Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Govender D, Kibera J, Carrara H, Saleh M. Sayed S, et al. Breast. 2014 Oct;23(5):591-6. doi: 10.1016/j.breast.2014.06.006. Epub 2014 Jul 7. Breast. 2014. PMID: 25012047 Free article.

9

Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.

Kuzhan A, Adli M, Eryigit Alkis H, Caglayan D. Kuzhan A, et al. J BUON. 2013 Jul-Sep;18(3):619-22. J BUON. 2013. PMID: 24065473 Free article.

10

Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.

Del Casar JM, Martín A, García C, Corte MD, Alvarez A, Junquera S, González LO, Bongera M, García-Muñiz JL, Allende MT, Vizoso F. Del Casar JM, et al. Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):147-52. doi: 10.1016/j.ejogrb.2008.07.021. Epub 2008 Sep 2. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 18768247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year